ALX ONCOLOGY HOLDINGS INC Quarterly Interest Expense in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Alx Oncology Holdings Inc quarterly/annual Interest Expense history and growth rate from Q1 2022 to Q3 2024.
  • Alx Oncology Holdings Inc Interest Expense for the quarter ending September 30, 2024 was $446K, a 14.1% increase year-over-year.
  • Alx Oncology Holdings Inc Interest Expense for the twelve months ending September 30, 2024 was $1.72M, a 24.3% increase year-over-year.
  • Alx Oncology Holdings Inc annual Interest Expense for 2023 was $1.57M, a 558% increase from 2022.
  • Alx Oncology Holdings Inc annual Interest Expense for 2022 was $238K, a 1731% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.72M $446K +$55K +14.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.66M $429K +$57K +15.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.61M $427K +$40K +10.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.57M $415K +$184K +79.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 $1.38M $391K +$389K +19450% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $992K $372K +$370K +18500% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $622K $387K +$384K +12800% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $238K $231K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $2K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $3K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.